Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Investment bank
|
| gptkbp:acquisition |
gptkb:Wainwright_Holdings
|
| gptkbp:affiliation |
gptkb:SIPC
gptkb:FINRA |
| gptkbp:CEO |
gptkb:Jeffrey_Wainwright
|
| gptkbp:community_involvement |
Philanthropic initiatives
Support for startups Sponsorship of healthcare events |
| gptkbp:conference |
gptkb:H.C._Wainwright_Global_Investment_Conference
|
| gptkbp:employeeCount |
Over 100
|
| gptkbp:focus |
Healthcare_sector
|
| gptkbp:founded |
1940
|
| gptkbp:founder |
gptkb:H.C._Wainwright
|
| gptkbp:has_a_focus_on |
Advisory services
Long-term relationships Tailored solutions |
| gptkbp:headquarters |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
H.C. Wainwright & Co.
|
| gptkbp:investmentFocus |
Mergers and acquisitions
Public offerings Growth-oriented Private placements Small and mid-cap companies |
| gptkbp:market |
gptkb:Asia
gptkb:Canada gptkb:United_States Europe |
| gptkbp:marketSegment |
Derivatives
Equities Fixed income |
| gptkbp:notableFeature |
Pharmaceutical companies
Biotechnology companies Medical device companies |
| gptkbp:partnerships |
Various healthcare firms
|
| gptkbp:reputation |
Innovative solutions
Respected in investment community Strong in healthcare |
| gptkbp:research |
Analysts team
|
| gptkbp:research_focus |
Market trends
Sector analysis Company analysis Over 300 companies |
| gptkbp:revenue |
$100 million (2020)
|
| gptkbp:services |
Equity research
Investment banking Sales and trading |
| gptkbp:subsidiary |
gptkb:H.C._Wainwright_Capital
|
| gptkbp:type |
Public company
|
| gptkbp:website |
hcwco.com
|